AGP Executive Report
Last update: 3 hours agoGLP-1 Legal Fight: Novo Nordisk sued Eli Lilly in U.S. District Court in New Jersey, accusing Lilly of “deliberately false” weight-loss drug advertising and using outdated trial comparisons. Drug Recalls: Unique Pharmaceutical Laboratories voluntarily recalled four lots of cetirizine hydrochloride tablets after potential cross-contamination with ranitidine (Zantac generic), and FDA also posted recall updates for other blood pressure drugs and allergy products. Public Health Watch: CDC reported 2,260 measles cases nationwide as of July 16, with summer travel driving new exposures as vaccination rates decline. Food Safety in NJ: Health officials tracked a growing cyclosporiasis outbreak tied to produce, including lettuce concerns, with NJ case counts cited in coverage and ongoing advisories. Local Health & Safety: A House hearing spotlighted Delaney Hall ICE detention center conditions in Newark, with lawmakers clashing over medical care and sanitation claims. NJ Health Infrastructure: New Brunswick’s HELIX life-science hub is expanding near the train station, aiming to boost Rutgers research and attract major employers like Nokia Bell Labs. Workforce & Care Access: NJEDA paused new Aspire tax credit applications, a move that could affect financing for housing and health-related development projects.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
